Literature DB >> 6288774

Complement biosynthesis by the human hepatoma-derived cell line HepG2.

K M Morris, D P Aden, B B Knowles, H R Colten.   

Abstract

The human hepatoma-derived cell line, HepG2, synthesized and secreted functional complement proteins C1r, C1s, C2, C3, C4, C5, factor B, C1 inhibitor, C3b inactivator, a small amount of C6, and trace amounts of C8; but failed to produce detectable C1q, C7, or C9. Immunochemically, C2, C3, C4, C5, and B were isolated from culture medium as proteins with molecular sizes and subunit structures identical to the corresponding components isolated from serum. C2 and factor B from cellular lysates had slightly lower molecular weights than the corresponding proteins in culture medium. C3, C4, and C5 were detected as single chain precursor molecules in cellular lysates. These results demonstrate that human C5, like C3 and C4, is synthesized as a single chain precursor that is converted by limited proteolysis to the native two-chain molecule. It also establishes the precursor-product relationship for human pro-C4 and native C4, pro-C5, and native C5.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6288774      PMCID: PMC370299          DOI: 10.1172/jci110687

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Cell-free synthesis of the fourth component of guinea pig complement (C4): identification of a precursor of serum C4 (pro-C4).

Authors:  R E Hall; H R Colten
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

2.  Genetic deficiency of the second component of complement (C2) associated with systemic lupus erythematosus. Relation of the complement abnormality and disease manifestations.

Authors:  R I Rynes; R E Urizar; R J Pickering
Journal:  Am J Med       Date:  1977-08       Impact factor: 4.965

Review 3.  Genetics of the complement system.

Authors:  C A Alper; F S Rosen
Journal:  Adv Hum Genet       Date:  1976

4.  Molecular characterization of the Ss and Slp (C4) proteins of the mouse H-2 complex: subunit composition, chain size polymorphism, and an intracellular (PRO-Ss) precursor.

Authors:  M H Roos; J P Atkinson; D C Shreffler
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

5.  A single chain precursor of C4 in human serum.

Authors:  I Gigli
Journal:  Nature       Date:  1978-04-27       Impact factor: 49.962

6.  Biosynthesis of the first component of complement by human fibroblasts.

Authors:  K B Reid; E Solomon
Journal:  Biochem J       Date:  1977-12-01       Impact factor: 3.857

7.  Biosynthesis of a single chain pro-C5 by normal mouse liver mRNA: analysis of the molecular basis of C5 deficiency in AKR/J mice.

Authors:  F Patel; J O Minta
Journal:  J Immunol       Date:  1979-11       Impact factor: 5.422

8.  Biosynthesis and post-synthetic modification of a precursor (pro-C5) of the fifth component of mouse complement (C5).

Authors:  Y M Ooi; H R Colten
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

9.  Biosynthesis of pro-C3, a precursor of the third component of complement.

Authors:  V Brade; R E Hall; H R Colten
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

10.  The first component of complement. A quantitative comparison of its biosynthesis in culture by human epithelial and mesenchymal cells.

Authors:  K M Morris; H R Colten; D H Bing
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

View more
  70 in total

1.  Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack.

Authors:  O B Spiller; O Criado-García; S Rodríguez De Córdoba; B P Morgan
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 2.  The effect of locally synthesised complement on acute renal allograft rejection.

Authors:  Steven Sacks; Wuding Zhou
Journal:  J Mol Med (Berl)       Date:  2003-06-25       Impact factor: 4.599

3.  Mutants of complement component C3 cleaved by the C4-specific C1-s protease.

Authors:  P Mathias; C J Carrillo; N E Zepf; N R Cooper; R T Ogata
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

Review 4.  Complement activation in progressive renal disease.

Authors:  Amy Fearn; Neil Stephen Sheerin
Journal:  World J Nephrol       Date:  2015-02-06

5.  Biosynthesis of complement C1 inhibitor by Hep G2 cells. Reactivity of different glycosylated forms of the inhibitor with C1s.

Authors:  M H Prandini; A Reboul; M G Colomb
Journal:  Biochem J       Date:  1986-07-01       Impact factor: 3.857

6.  Characterization of shark complement factor I gene(s): genomic analysis of a novel shark-specific sequence.

Authors:  Dong-Ho Shin; Barbara M Webb; Miki Nakao; Sylvia L Smith
Journal:  Mol Immunol       Date:  2009-05-07       Impact factor: 4.407

7.  Phosphorylation of complement component C3 after synthesis in U937 cells by a putative protein kinase, casein kinase 2, which is regulated by CD11b: evidence that membrane-bound proteases preferentially cleave phosphorylated C3.

Authors:  K Nilsson Ekdahl; B Nilsson
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

8.  Analysis of synthetic sites of fourth and fifth components of serum complement system in allogeneic bone marrow chimaeras.

Authors:  L Geng; K Iwabuchi; S Sakai; M Ogasawara; M Fujita; K Ogasawara; M Kakinuma; R A Good; K Morikawa; K Onoé
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

9.  DNase I hypersensitivity mapping and promoter polymorphism analysis of human C4.

Authors:  A K Vaishnaw; R Hargreaves; R D Campbell; B J Morley; M J Walport
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

10.  Isolation of a complementary DNA clone for the human complement protein C2 and its use in the identification of a restriction fragment length polymorphism.

Authors:  D E Woods; M D Edge; H R Colten
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.